The Travelers Companies, Inc. today announced that it has developed the first predictive model designed to reverse a sharp rise in chronic pain caused by workplace injuries. The patent-pending Travelers Early Severity Predictor identifies the likelihood of an injured employee developing chronic pain so that they can avoid it in recovery and reduce the need to use opioids or other painkillers.
The Travelers Early Severity Predictor has been applied in more than 20,000 cases since early 2015. Of those, more than 9,000 injured employees were identified as being at risk of developing chronic pain. These employees received a customized, sports medicine-like regimen of treatment precisely sequenced to aid and accelerate their recovery.
Injured employees who participated in the program in the past year have, on average, recovered and returned to work more quickly. They were also far less likely to receive a prescription for opioids, and when they did, it was typically a lower dosage or only for short-term use. At the same time, medical expenses, which cost American employers an average of nearly $40,000 per injury, were reduced by as much as 50 percent.